Skip to main content
. Author manuscript; available in PMC: 2017 Oct 25.
Published in final edited form as: Drug Metab Lett. 2015;9(1):48–62. doi: 10.2174/1872312809666150119110200

Fig. (4).

Fig. (4)

Inhibitory effects of 50 µg/mL of each fraction on CYP3A4 and CY2C19 preincubated for 30 mins in the presence or absence of NADPH. The percent residual activities were plotted against respective fractions. Two tailed unpaired t-test were used to compare the percent activity remaining for each fraction with P < 0.05 considered significant.